Accès à distance ? S'identifier sur le proxy UCLouvain
Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
Primary tabs
- Open access
- 1.79 M
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2018 |
Language | Anglais |
Journal information | "International journal of pharmaceutics" - Vol. 548, no. 1, p. 522-529 (2018) |
Peer reviewed | yes |
Publisher | Elsevier/North-Holland Biomedical Press ((Netherlands) Amsterdam) |
issn | 0378-5173 |
e-issn | 1873-3476 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/MONT - Pôle Mont Godinne UCL - (MGD) Service de neurochirurgie UCL - SSS/LDRI - Louvain Drug Research Institute UCL - SSS/IONS/NEUR - Clinical Neuroscience |
Keywords | Glioblastoma ; Hydrogel ; Local delivery ; Orthotopic model ; PLGA nanoparticles ; Paclitaxel |
Links |
Bibliographic reference | Zhao, Mengnan ; Danhier, Fabienne ; Bastiancich, Chiara ; Joudiou, Nicolas ; Ganipineni, Lakshmi Pallavi ; et. al. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.. In: International journal of pharmaceutics, Vol. 548, no. 1, p. 522-529 (2018) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/201135 |